期刊文献+

半定量RT-PCR检测服用甲磺酸伊马替尼慢性粒细胞性白血病患者hOCT1的表达 预览

To Detect the Expression of hOCT1 by Semi-quantity RT-PCR in Chronic Myelogeneous Leukemia Patients Treated with Imatinib Mesylate
在线阅读 下载PDF
分享 导出
摘要 目的:动态检测慢性粒细胞白血病( CML)患者服用伊马替尼缓解或耐药前后的hOCT1基因表达变化,初步探讨hOCT1基因表达变化与疾病缓解或伊马替尼耐药相关性。方法采用半定量RT-PCR方法对服用伊马替尼CML患者缓解或耐药前后的2个不同时点的9对(18份)标本进行了hOCT 1基因mRNA水平检测,并对半定量RT-PCR结果结合临床表现、实验室检查和细胞遗传学结果,分析其水平变化和与疾病缓解或伊马替尼耐药相关性。结果慢性期CML患者5例,第一和二次检测hOCT1相对表达量为(0.4246±0.2067)、(0.4858±0.1943),P=0.705,差异无统计学意义。对进展期CML患者4例前后两次hOCT1相对表达量比较,有3例患者hOCT1相对表达量降低,1例患者hOCT1相对表达量升高。结论半定量RT-PCR方法方便简单,可以用于检测服用伊马替尼的CML患者hOCT1基因表达及变化,或许有可能用于慢性粒细胞白血病伊马替尼反应或耐药的检测及其机制的研究。 Objective To monitor hOCT1 gene expression in CML patients treated with imatinb mesylate and observe the correlation between hOCT1 gene variation and BCR-ABL molecular response conditions. Methods By semi-quantity RT-PCR (SQ-PCR), hOCT1 gene mRNA levels were detected from 9 pairs of (18) samples on two different time points around the course of response or drug resistance to imatinib in patients with chronic myelogenous leukemia respectively. The results of their SQ-PCRs were compared with clinical presentations, laboratory detections and cytogenetic findings thereof, to get some information on the correlation between changes of hOCT1 gene levels and disease response or resistance to imatinib. Results The relative expression levels of hOCT1 gene were(0. 4246±0. 2067),(0. 4858±0. 1943), with P=0. 705 and without statistical significance in both tests 1 and 2 in 5 patients with chronic myelogenous leukemia in chronic phase, respectively. The relative expression levels of hOCT1 gene between two tests increased in 3 and decreased in 1 of 4 patients with advanced stage of chronic myelogenous leukemia respectively. Conclusion This study established a relatively simple and useful method to detect hOCT1 gene expression that prob-ably can be used in the study on imatinib resistance.
作者 刘恒伟 朱焕玲 孟文彤 刘霆 Liu Hengwei,Zhu Huanling ,Meng Wentong ,et al. (1. The Third People's Hospital of Chengdu,Chengdu , Sichuan 610031 ;2. West China Hospital, Sichuan University, Chengdu , Sichuan 610041, China)
出处 《四川医学》 CAS 2014年第4期435-437,共3页 Sichuan Medical Journal
关键词 半定量RT-PCR 慢性粒细胞白血病 伊马替尼 hOCT1 半定量RT-PCR semi-quantity RT-PCR,chronic myelogenous leukemia imatinib
作者简介 通讯作者
  • 相关文献

参考文献4

  • 1Thomas J, Wang L, Clark RE,et al. Active transport of imatinib into and out of cells : implications for drug resistance [ J ]. Blood,2004,104 (12) :3739-3745. 被引量:1
  • 2Lucy CC, Brian JD, Michael WND, et al. hOCT 1 and resistance to imatinib [J]. Blood, 2005,106 (3): 1133-1134. 被引量:1
  • 3Kerb R, Brinkmann U, Chatskaia N, et al. Identification of genetic var- iations of the human organic cation transporter hOCT1 and their func- tional consequences [J]. Pharmacogeneties, 2002,12(8) :591-595. 被引量:1
  • 4Roumiantsev S, Shah NP, Gorre ME, et al. Clinical resistance to thekinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop[J]. Proc Natl Acad Sei U S A,2002,99 ( 16 ) : 10700-10705. 被引量:1
投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈